Periodic Reporting for period 1 - XVR011 Phase 2 (ExeVir's XVR011, a best in class nanobody-based biology that broadly neutralizes SARS-COV-1 and SARS-COV-2)

XVR011, ExeVir’s lead candidate in 2021, emerged from the scientific research from the labs of highly regarded virologist Xavier Saelens and biochemist Nico Callewaert. Nonclinical data on the discovery and nonclinical development had been published in Cell and, as a...